Home
About
Overview
Sharing Data
ORCID
Help
History (4)
"It's not what you say ...": racial disparities in communication between orthopedic surgeons and patients.
A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma.
Electrodiagnosis
Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma.
A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma. Am J Clin Oncol. 2011 Apr; 34(2):150-4.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Capecitabine
Chicago
Deoxycytidine
Drug-Related Side Effects and Adverse Reactions
Female
Fluorouracil
Humans
Kidney Neoplasms
Male
Middle Aged
Molecular Targeted Therapy
Neoplasm Metastasis
Survival Analysis
authors with profiles
Olwen Hahn
Theodore Karrison